Advance in H3 histamine receptor ligands

Chinese Pharmaceutical Journal

Volumn 42, Issue 6, 2007, Pages 404-409

  Wu, Jun ^a   Mi, Jia Li ^a   Zhou, Cheng He ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; 5 (4 CYANOPHENYL) 2 [2 (2 METHYL 1 IMIDAZOLIDINYL)ETHYL]BENZOFURAN; A 317920; A 331440; A 423579; CIPRALISANT; CIPROXIFAN; CLOBENPROPIT; FUB 172; FUB 649; FUB 836; GT 2331; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; IMBUTAMINE; IMETIT; IMMEPIP; IMMETHRIDINE; IMOPROXIFAN; IMPENTAMINE; JNJ 10181457; JNJ 5207852; LIGAND; METHIMEPIP; PROXYFAN; SCH 79687; THIOPERAMIDE; UCL 1972; UNCLASSIFIED DRUG; UNINDEXED DRUG; VUF 5391;

ARTICLE; ATTENTION DEFICIT DISORDER; DRUG STRUCTURE;

EID: 54549085643     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 1-antihistamines[J]. N Engl J Med, 2004, 351(21) : 2203-2217.
2. 2 receptor ligands[J]. Mini Rev Med Chem, 2004, 4(9) : 941-954.
3. 3 receptor antagonists[J]. Mini Rev Med Chem, 2004, 4(9) : 965-977.
4. 3 receptor agonists[J]. Mini Rev Med Chem, 2004, 4(9) :955-963.
5. 3-receptors[J]. Eur J Pharm Sci, 2004, 23(1) : 89-98.
6. 3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system[J]. Pharmacol Ther, 2004, 103(1) : 1-20.
7. 3 receptor drugs[J]. Nat Rev Drug Discovery, 2005, 4(2) : 107-120.
8. 3-receptor ligands: potential therapeutic uses[J]. Pharm Care Res, 2004, 4(3) : 183-187.
9. 3 receptor[J]. Neuropharmacology, 2002, 42(7) : 929-940.
10. 3 receptor agonists[J]. J Med Chem, 1995, 38(20) : 4070-4079.
11. 3 receptor agonists[J]. J Med Chem, 2003, 46(25) : 5445-5457.
12. 3 receptor agonist[J]. J Med Chem, 2004, 47(10) : 2414-2417.
13. 3 receptor agonist[J]. J Med Chem, 2005, 48(6) : 2100-2107.
14. 3 receptors in murine allergic rhinitis[J]. Laryngoscope, 2005, 115(10) : 1778-1784.
15. 3 receptor antagonis[J]. Eur J Pharmacol, 2004, 487(1-3) : 183-197.
16. 3-antagonists[J]. Bioorg Med Chem, 2004, 12(4) : 663-674.
17. GRASSMANN S, APELT J, SIPPL W, et al. Histamine N-methyltransferase potencies and histamine hH3 receptor affinities[J]. Bioorg Med Chem, 2003, 11(10) : 2163-2174.
18. 3-antagonists endowed with NO-donor properties[J]. Bioorg Med Chem, 2003, 11(7) : 1197-1205.
19. 3-receptor antagonist imoproxifan and related furazan derivatives[J]. Bioorg Med Chem, 2005, 13(15) : 4750-4759.
20. 3-antagonists[J]. Farmaco, 2005, 60(6-7) : 507-512.
21. 3-antagonists[J]. Eur J Med Chem, 2005, 40(1) : 15-23.
22. 3 receptor antagonists of the carbamateseries: the alkyl derivatives[J]. Pharmazie, 2005, 60(6) : 403-410.
23. 3 receptor antagonist with drug-like properties[J]. J Pharmacol Exp Ther, 2005, 313(1) : 165-175.
24. 3 receptor antagonists [J]. Bioorg Med Chem Lett, 2005, 15(10) :2559-2563.
25. 3 receptor antagonists potently enhance cognition and attention[J]. J Med Chem, 2005, 48(1) : 38-55.
26. 3 antagonists[J]. J Med Chem, 2005, 48(6) : 2229-2238.
27. 3 receptor antagonists[J]. J Med Chem, 2005, 48(1) :306-311.
28. 3 receptor antagonists with combined inhibitory potency at Ntau-methyltransferase: ether derivatives[J]. Pharmazie, 2005, 60(2) : 97-106.
29. AKHTAR M, PILLAI K K, VOHORA D. Effect of thioperamide on modified forced swimming test-induced oxidative stress in mice [J]. Basic Clin Pharmacol Toxicol, 2005, 97(4) : 218-221.
30. 3 receptor antagonists in two models of spatial learning[J]. Behav Brain Res, 2005, 159(2) : 295-300.